Award recordCONTRACT

NOVARTIS PHARMACEUTICALS CORPORATION

PIID 36C26226F0048· VHA· 262-NETWORK CONTRACT OFFICE 22 (36C262)· 6505 · DRUGS AND BIOLOGICALS· FY2026· $1,023,071 net obligations· UEI NG61ZA8TADW3· NJ

Description

PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML)

First action · last action
2025-12-30 · 2026-01-20
Transactions
2
First transaction's obligation
$1,023,071
Base + all options value (sum of deltas)
$4,984,371
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79720D0180
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1,023,071$0Base award · 2025-12-30 · this action $1,023,071 · running total $1,023,071Modification P00001 · 2026-01-20 · this action $0 · running total $1,023,071
  • Base2025-12-30+$1,023,071= $1,023,071
  • Mod P000012026-01-20+$0= $1,023,071
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2025-12-30+$1,023,071$1,023,071PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML)
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2026-01-20+$0$1,023,071PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML)

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI NG61ZA8TADW3)

AwardOffice · PSC / listingNet obligationsFY
36C25526N0394255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS$891,651FY2026
36C26226F0314262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$823,062FY2026
36C24526N0724245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$34,874FY2026
36C24526N0622245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$34,874FY2026
36C25026N0416250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$617,297FY2026
36C24526N0566245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$34,874FY2026

Other recipients under 6505 from 262-NETWORK CONTRACT OFFICE 22 (36C262) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26226N0872CENTRAL ADMIXTURE PHARMACY SERVICES, INC262-NETWORK CONTRACT OFFICE 22 (36C262)$164,265FY2026
36C26226N0873CENTRAL ADMIXTURE PHARMACY SERVICES, INC262-NETWORK CONTRACT OFFICE 22 (36C262)$140,823FY2026
36C26226N0871CENTRAL ADMIXTURE PHARMACY SERVICES, INC262-NETWORK CONTRACT OFFICE 22 (36C262)$231,746FY2026
36C26226N0870CENTRAL ADMIXTURE PHARMACY SERVICES, INC262-NETWORK CONTRACT OFFICE 22 (36C262)$167,369FY2026
36C26226P1412ASD SPECIALTY HEALTHCARE, LLC262-NETWORK CONTRACT OFFICE 22 (36C262)$38,220FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26226F0048_3600_36F79720D0180_3600 · retrieved 2026-09-26.